Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data
- PMID: 10323443
- DOI: 10.1002/1529-0131(199905)42:5<882::AID-ANR6>3.0.CO;2-C
Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data
Abstract
Objective: To describe the frequency of self-reported fractures in a large population-based cohort of women with lupus, to compare the frequency of self-reported fractures between lupus patients and women of similar age in the general population by use of data from the 1994 National Health Interview Survey (NHIS), and to describe the associated risk factors for fracture in women with lupus. This study is a secondary analysis of data collected to assess cardiovascular risk in women with lupus.
Methods: Fractures and associated risk factors were ascertained by self report in this retrospective cohort study of 702 living women with lupus who were followed up for 5,951 person-years. Self-reported fractures were verified in a subset of patients. A Weibull regression model was used to assess risk factors associated with time from lupus diagnosis to fracture in the univariate and multivariate analyses. Age-specific standard morbidity ratios (SMRs) were calculated to determine whether fracture occurrence was greater than expected in women with lupus.
Results: Eighty-six (12.3%) of 702 women reported at least 1 fracture following the diagnosis of lupus. The sites of the first fracture were the leg (n = 32), foot (n = 16), arm (n = 15), spine (n = 9), rib (n = 7), hip (n = 2), pelvis (n = 2), hand (n = 1), shoulder (n = 1), and finger (n = 1). Fracture risk was increased in the lupus cohort compared with women of similar age from the United States population, using weighted data from the 1994 NHIS (SMR 4.7; 95% confidence interval 3.8, 5.8). Variables in the univariate analysis that were significantly associated (P < 0.05) with time from lupus diagnosis to fracture were older age at lupus diagnosis, longer disease duration, longer duration of corticosteroid use, less use of oral contraceptives, and menopause status. In the multivariate analysis, independent determinants of time from lupus diagnosis to fracture were older age at lupus diagnosis and longer duration of corticosteroid use.
Conclusion: Fractures occurred in 12.3% of lupus patients who were followed up for 5,951 person-years. There was nearly a 5-fold increase in fracture occurrence in the women with lupus compared with women from the US population. Older age at lupus diagnosis and longer use of corticosteroids were associated with time from lupus diagnosis to fracture. With increased life expectancy of lupus patients, fracture occurrence is a major threat to the health of these women. Prevention strategies must be directed toward minimizing the occurrence of fractures in these patients.
Similar articles
-
Increased risk of fracture in patients receiving solid organ transplants.J Bone Miner Res. 1999 Mar;14(3):456-63. doi: 10.1359/jbmr.1999.14.3.456. J Bone Miner Res. 1999. PMID: 10027911
-
Self-reported fractures and associated factors in women with systemic lupus erythematosus.J Rheumatol. 2007 Oct;34(10):2018-23. Epub 2007 Sep 1. J Rheumatol. 2007. PMID: 17787041
-
Central nervous system active medications and risk for fractures in older women.Arch Intern Med. 2003 Apr 28;163(8):949-57. doi: 10.1001/archinte.163.8.949. Arch Intern Med. 2003. PMID: 12719205
-
Use of oral corticosteroids and risk of fractures.J Bone Miner Res. 2000 Jun;15(6):993-1000. doi: 10.1359/jbmr.2000.15.6.993. J Bone Miner Res. 2000. PMID: 10841167 Review.
-
Systemic lupus erythematosus, bone health, and osteoporosis.Curr Opin Endocrinol Diabetes Obes. 2015 Dec;22(6):422-31. doi: 10.1097/MED.0000000000000197. Curr Opin Endocrinol Diabetes Obes. 2015. PMID: 26414079 Review.
Cited by
-
Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis.Front Immunol. 2022 Dec 2;13:839197. doi: 10.3389/fimmu.2022.839197. eCollection 2022. Front Immunol. 2022. PMID: 36532018 Free PMC article.
-
Management of glucocorticoid-related osteoporotic vertebral fracture.Osteoporos Sarcopenia. 2020 Mar;6(1):1-7. doi: 10.1016/j.afos.2020.02.002. Epub 2020 Mar 3. Osteoporos Sarcopenia. 2020. PMID: 32226826 Free PMC article. Review.
-
Lupus nephritis.Nat Rev Dis Primers. 2020 Jan 23;6(1):7. doi: 10.1038/s41572-019-0141-9. Nat Rev Dis Primers. 2020. PMID: 31974366 Review.
-
Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy.Core Evid. 2019 Aug 23;14:41-50. doi: 10.2147/CE.S172820. eCollection 2019. Core Evid. 2019. PMID: 31692480 Free PMC article.
-
Incidence and risk factors for osteoporotic fractures in patients with systemic lupus erythematosus versus matched controls.Korean J Intern Med. 2021 Jan;36(1):154-163. doi: 10.3904/kjim.2018.378. Epub 2019 Jun 26. Korean J Intern Med. 2021. PMID: 31234614 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical